
[Federal Register: July 29, 2008 (Volume 73, Number 146)]
[Notices]               
[Page 43940]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr29jy08-62]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2007-P-0300] (formerly 2007P-0326)

 
Determination That SANOREX (Mazindol) Tablets 1 and 2 Milligrams 
Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness; 
Correction

AGENCY:  Food and Drug Administration. HHS.

ACTION:  Notice; correction.

-----------------------------------------------------------------------

SUMMARY:  The Food and Drug Administration is correcting a notice that 
appeared in the Federal Register of July 15, 2008 (73 FR 40582). The 
document announced the determination that SANOREX (mazindol) Tablets, 1 
and 2 milligrams (mg), were not withdrawn from sale for reasons of 
safety or effectiveness. The document was published with an incorrect 
docket number. This document corrects that error.

FOR FURTHER INFORMATION CONTACT: Joyce Strong, Office of Policy and 
Planning (HF-27), Food and Drug Administration, 5600 Fishers Lane, 
Rockville, MD 20857, 301-827-7010.

SUPPLEMENTARY INFORMATION: In FR Doc. E8-15998, appearing on page 40582 
in the Federal Register of Tuesday, July 15, 2008, the following 
correction is made:
    1. On page 40582, in the third column, in the headings section of 
the document, ``[Docket No. FDA-2007-P-0326]'' is corrected to read 
``[Docket No. FDA-2007-P-0300] (formerly 2007P-0326)''.

    Dated: July 22, 2008.
Jeffrey Shuren,
Associate Commissioner for Policy and Planning.
[FR Doc. E8-17303 Filed 7-28-08; 8:45 am]

BILLING CODE 4160-01-S
